MMT
Dead / Abandoned — Abandoned — no statement of use filed (as of 28 Nov 2022)
What this means for you
This application is over — abandoned 28 Nov 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88235670
- Mark type
- Stylized text
- Filed
- 19 Dec 2018
- Published for opposition
- 27 Aug 2019
- Abandoned
- 28 Nov 2022
- Attorney of record
- Christina M. Licursi, Esq.
Goods and services
- Class 005 — Pharmaceuticals: therapeutic pharmaceuticals for medical use for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders, obesity, and diabetes in humans; dietetic foods adapted for medical use; dietary supplements; nutritional supplements; nutraceuticals for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders, obesity, and diabetes in humans; medical diagnostic reagents and assays for testing body fluids for microorganisms for modifying the microbial composition or metabolic output of the human microbiome
Owner
- Kaleido Biosciences, Inc., Lexington, MA, US
- Kaleido Biosciences, Inc., Lexington, MA, US
Prosecution history
- 28 Nov 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 28 Nov 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 28 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Apr 2022 — SOU EXTENSION 5 GRANTED
- 22 Apr 2022 — SOU EXTENSION 5 FILED
- 27 Apr 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Apr 2022 — SOU TEAS EXTENSION RECEIVED
- 19 Oct 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Oct 2021 — SOU EXTENSION 4 GRANTED
- 15 Oct 2021 — SOU EXTENSION 4 FILED
- 15 Oct 2021 — SOU TEAS EXTENSION RECEIVED
- 20 Apr 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Apr 2021 — SOU EXTENSION 3 GRANTED
- 16 Apr 2021 — SOU EXTENSION 3 FILED
- 16 Apr 2021 — SOU TEAS EXTENSION RECEIVED